Vivos Therapeutics, Inc. (VVOS)
NASDAQ
Vivos Therapeutics, Inc. Operating Income 2019–2025
Vivos Therapeutics, Inc. annual/quarterly operating income history and growth rate from 2019 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Vivos Therapeutics, Inc. operating income for the quarter ending March 31, 2026 was -6.6 M, a 68.84% increase year-over-year.
- Vivos Therapeutics, Inc. operating income for the twelve months ending March 31, 2026 was -20.1 M, a 67.68% increase year-over-year.
- Vivos Therapeutics, Inc. annual operating income for 2025 was -19.9 M, a 78.09% increase from 2024.
- Vivos Therapeutics, Inc. annual operating income for 2024 was -11.2 M, a 35.41% decrease from 2023.
- Vivos Therapeutics, Inc. annual operating income for 2023 was -17.3 M, a 30.90% decrease from 2022.
- Vivos Therapeutics, Inc. annual operating income for 2022 was -25.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vivos Therapeutics, Inc. Operating Income — FAQ
Vivos Therapeutics, Inc. (VVOS) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Vivos Therapeutics, Inc.'s operating income?
Vivos Therapeutics, Inc. (VVOS) reported operating income of -$20M for fiscal 2025.
Where can I see VVOS's operating income history?
The chart and table above show Vivos Therapeutics, Inc.'s operating income by year and by quarter, including the growth rate.